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Abstract
Background: Iron is necessary for neuronal function but in excess generates neurodegeneration.
Although most of the components of the iron homeostasis machinery have been described in
neurons, little is known about the particulars of their iron homeostasis. In this work we
characterized the response of SH-SY5Y neuroblastoma cells and hippocampal neurons to a model
of progressive iron accumulation.
Results: We found that iron accumulation killed a large proportion of cells, but a sub-population
became resistant to iron. The surviving cells evoked an adaptative response consisting of increased
synthesis of the iron-storage protein ferritin and the iron export transporter IREG1, and decreased
synthesis of the iron import transporter DMT1. Increased expression of IREG1 was further
substantiated by immunocytochemistry and iron efflux experiments. IREG1 expression directly
correlated with iron content in SH-SY5Y and hippocampal cells. Similarly, a high correlation was
found between IREG1 expression and the rate of iron efflux from SH-SY5Y cells.
Conclusions: Neuronal survival of iron accumulation associates with increased expression of the
efflux transporter IREG1. Thus, the capacity of neurons to express IREG1 may be one of the clues
to iron accumulation survival.
Background
Because of its intense oxidative metabolism, the brain
consumes a high fraction of total oxygen generating large
amounts of reactive oxygen species [1,2]. Although brain
antioxidant defenses function properly during most of
human life, a number of neurodegenerative processes
which involve redox-active iron accumulation become
evident with age [3-5]. Iron is a pro-oxidant that in the
reductive intracellular environment catalyses hydroxyl
radical formation through the Fenton reaction [6]. At
present, the crucial components of the iron homeostasis
machinery have been identified. Thus, current efforts
should be directed to the understanding of the mecha-
nisms that regulate cellular iron levels and antioxidant
defenses. This is of primary importance for the develop-
ment of strategies to ameliorate iron accumulation and
oxidative damage in neurons.
In vertebrates, cellular iron levels are post-transcription-
ally controlled by the activity of iron regulatory proteins
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(IRP1 and IRP2), cytosolic proteins that bind to structural
elements called iron-responsive elements (IREs). IREs are
found in the untranslated region of the mRNAs of the
major proteins that regulate cellular iron homeostasis: the
transferrin receptor, involved in plasma-to-cell iron trans-
port, and the iron-storage protein ferritin. IRP2-/- mice are
born normal but in adulthood develop a movement dis-
order characterized by ataxia, bradykinesia and tremor
[7]. IRP1-/- mice are normal with slight misregulation of
iron metabolism in the kidney and brown fat [8]. Thus,
IRP2 seems to dominate the physiological regulation of
iron metabolism whereas IRP1 seems to predominate in
pathophysiological conditions.
Iron is internalized into cells by the import transporter
DMT1. Four DMT1 isoforms have been identified that dif-
fer in both the N-and the C-termini [9]. Two of the iso-
forms have a 3' iron responsive element (IRE) in their
mRNA. Additional variation is given by exons 1A and 1B
in the 5' end. Expression of DMT1 in response to iron
availability follows a pattern similar to transferrin recep-
tor [10], but its control by the IRE/IRP system is not clear
[for review see [11]].
A new iron transporter, IREG1, also known as ferroportin
or MTP1, was recently described [12,13]. The protein is
expressed mainly in enterocytes and macrophages
[reviewed in [14]]. In enterocytes IREG1 is responsible for
iron efflux during the process of intestinal iron absorp-
tion, while in Kupffer cells IREG1 mediates iron export for
reutilization by the bone marrow [15]. The presence of
both DMT1 and IREG1 has been described in neurons,
glioma cells and astrocytes [16-18]. The presence of
IREG1 in neurons opens the possibility that they may be
able to down-regulate intracellular iron concentration
through its expression.
In this study we examined iron homeostasis in SH-SY5Y
neuroblastoma cells and hippocampal neurons. We
found that iron accumulation killed a large proportion of
cells, but a sub-population became resistant to iron accu-
mulation developing an adaptative mechanism intended
to decrease intracellular iron content.
Results
Iron accumulation and cell death
Iron accumulation was determined in SH-SY5Y cells
grown to confluence and then cultured for two days in
media containing from 1.5 to 80 µM iron (Figure 1A).
Total cell iron increased with increasing extracellular iron,
reaching a plateau at 40–80 µM Fe (Figure 1B). The
observed increase in cell iron was accompanied by
increases in the labile iron pool (Figure 1C). Iron accumu-
lation indeed caused loss of cell viability, with hippocam-
pal neurons demonstrating higher sensitivity than SH-
SY5Y cells to iron treatment (Figure 2). Nevertheless, a
sub-population of cells survived to high iron concentra-
tions. It was of interest to inquire into the processes
underlying this adaptation, since they could help to
understand iron accumulation observed in a number of
neurodegenerative diseases. Consequently, we character-
ized the components of the iron homeostasis machine
during the process of iron accumulation.
Ferritin and DMT1 regulation
Ferritin, the main iron-storage protein in mammalian
cells, is considered the first line of defense against iron
overload. Increasing iron from 1.5 to 5 µM produced a
robust 4-fold increase in cell ferritin content (Figure 3A).
Further increases in iron induced additional increases in
ferritin. At 80 µM extracellular iron, ferritin increased 11-
fold compared to the basal 1.5 µM iron condition. In
molar base, ferritin increased more than iron. The iron to
ferritin mol : mol ratio decreased from 1500 at 1.5 µM Fe
to 400 at 10 µM Fe to 200 at 80 µM Fe (Figure 3B).
We further characterized iron homeostasis in SH-SY5Y
cells by examining the expression of the iron importer
DMT1 (Figure 4). A 3.5-fold decrease in DMT1 protein
expression was observed when iron increased from 1.5 to
80 µM. The presence of DMT1 even at high iron concen-
tration explains the sustained iron uptake observed at 80
µM Fe [19]. Thus, DMT1 activity persisted even under con-
ditions of iron accumulation that preceded cell death.
IREG1 expression and functionality
Given that the presence of IREG1 in the central nervous
system has been   reported [[16]], it was of interest to
examine if it participates in neuronal iron homeostasis.
Western blot analysis revealed that SH-SY5Y cells
expressed anti-IREG1 reactive bands of 65.3 and 122.1
KDa molecular weight (Figure 5A). Densitometric analy-
sis revealed a 10-fold increase in the 122.1 KDa band in
the 1.5 to 80 mM Fe range while the 65.3 band had a
minor increase (Figure 5A). Both bands were eliminated if
the antibody was   incubated with the immunogenic pep-
tide before the assay (Figure 5B). A similar pattern was
obtained with an independent anti-IREG1 antibody (the
kind gift of Dr. David Haile). Thus, it is most likely that
the 65.3 and   122.1 KDa bands correspond to the mono-
mer and dimer of IREG1. The stability of the 122.1 KDa
band was dependent of the concentration of b-mercap-
toethanol in the sample buffer since increasing b-mercap-
toethanol produced a shift in the 122.1 KDa /65.3 KDa
band ratios (Figure 5C). It is possible that in neuronal
cells Ireg1 tends to form S-S bridged dimers resistant to
the electrophoresis conditions.
The presence of IREG1 in SH-SY5Y neuroblastoma cells
and hippocampal neurons was further documented byBMC Neuroscience 2005, 6:3 http://www.biomedcentral.com/1471-2202/6/3
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Total and labile iron in the progressive iron accumulation model Figure 1
Total and labile iron in the progressive iron accumulation model A: SH-SY5Y cells were grown for 8 days and then 
challenged for 2 days with different concentrations of iron (range 1.5–80 µM). B: total iron content determined by mass spec-
trometry. Increased level of iron in the culture media produced increased levels of intracellular iron. Data is mean ± SD of 4 
independent determinations. C: The calcein-sensitive iron pool increased at 80 µM Fe compared with 7 µM Fe. Representative 
tracings are shown.
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immunocytochemistry. IREG1 was detected in both types
of cells, with a predominantly cytosolic distribution pat-
tern (Figure 6). The levels of IREG1 expression were
directly proportional to the amount of iron in the culture.
Thus, it was determined by two independent methods
that IREG1 expression in neuronal cells increased with
cell iron content.
Efflux of iron from neurons has never been reported. In
view of the presence of IREG1, we tested whether SH-SY5Y
cells actually had an iron efflux function. To that end, iron
efflux from cells pre-cultured for 2 days with varied iron
concentrations was determined by atomic absorption
spectrometry. This method was preferred to the use of
radioisotopic iron since the latter could underestimate a
putative iron efflux because of isotope dilution with the
pre-existing iron pool (see Figure 1B). SH-SY5Y cells had
discrete but measurable iron efflux activity (Figure 7A).
The iron efflux rate increased markedly in the 20–80 µM
Fe range (Figure 7B). Interestingly, the efflux rate corre-
lated closely with the presence of the 122.1 KDa band,
while the correlation between efflux activity and the 62.5
KDa band was weaker (Figure 7C).
Discussion
The number of neurological diseases associated with iron
accumulation in the brain underlines the need for
increased knowledge of the mechanisms of brain iron
homeostasis. In this study we show that iron accumula-
tion by SH-SY5Y neuroblastoma cells and hippocampal
neurons resulted in cell death of part of the population,
while another fraction survived by adapting the expres-
sion of iron homeostasis proteins.
Iron content increased significantly as a function of Fe in
the culture up to 20–40 µM Fe, increasing very little there-
after up to 80 µM Fe. Cell iron increase was accompanied
by increased ferritin content. The increase in ferritin more
than compensated for the increase in iron. Iron to ferritin
mol ratios of 1500, 260 and 190 were obtained for 1.5, 20
and 80 µM Fe in the culture media. Thus, the IRE/IRP sys-
tem of SH-SY5Y cells over-responded to iron accumula-
tion in terms of ferritin expression. Despite the increase in
ferritin, the LIP increased between 1.5 and 80 µM Fe. This
finding clearly indicates that in SH-SY5Y cells the level of
labile iron is a function of total iron, even in the presence
of ample ferritin supply. It is possible that ferritin-stored
Cell viability upon iron load Figure 2
Cell viability upon iron load. SH-SY5Y cells and hippocampal neurons were subjected to the progressive iron accumulation 
protocol described in Figure 1A. Viability in the cell cultures was determined by the MTT method. Representative curves from 
4 (SH-SY5Y cells) or 3 (hippocampal cells) independent experiments are shown.
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iron contributes to the LIP each time that ferritin undergo
lisosomal degradation.
Iron accumulation was accompanied by a marked
decrease in DMT1 expression. Nevertheless, some DMT1
persisted even at 40–80 µM iron. The persistence of DMT1
at high iron concentrations could underline the continu-
ous iron uptake observed under these conditions [19].
This is curious because at 40–80 µM Fe cells were dying.
Sustained DMT1 expression points to the inability of neu-
ronal cells to shut-off iron uptake and the need for addi-
tional defense mechanisms to prevent iron-mediated cell
death.
The discovery of increased IREG1 expression in response
to cell iron accumulation is a major break-through in the
understanding of cell survival under conditions of iron
accumulation. Total IREG1, and especially a putative
IREG1 dimer, increased markedly in the 20–80 µM Fe
range. Thus, in SH-SY5Y cells IREG1 is up-regulated by
increased cell iron. Expressed IREG1 was functional since
it associated with increased iron efflux activity. Iron efflux
activity in astrocytes [18] and neurons (this work) indi-
cate that iron efflux from brain cells is a dynamic process,
and highlights the importance of iron transporters as
determinants of iron accumulation.
The regulation of IREG1 expression is unknown but seems
to be cell-specific. In enterocytes, IREG1 expression is
induced by iron deficiency [13] while in macrophages
iron increases IREG1 expression [20]. The findings
reported here indicate that in neuronal cells IREG1 has a
macrophage-like regulation. This is certainly the case for
cells in the 40–80 µM range that survived to iron accumu-
lation. IREG1's predominantly cytosolic distribution pat-
tern is similar to that of Kupffer cells [12]. Again, this
distribution points to macrophage-like behavior of neuro-
nal IREG1. In examining brain biopsies from Alzheimer's
Ferritin content Figure 3
Ferritin content A: ferritin was determined in extracts from cells cultured for 2 days with different iron concentrations as 
described in Figure 1A. Data is mean ± SD from 4 independent determinations. B: iron : ferritin molar ratio. Total iron and fer-
ritin total data were from Figure 1B and 3A, respectively. Ferritin synthesis response was larger that iron accumulation, an indi-
cation of a very active IRE/IRP system.
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Changes in DMT1 expression Figure 4
Changes in DMT1 expression Upper panel: DMT1 from cells cultured for 2 days with different iron concentrations was 
determined by Western blot. A continuous decrease in DMT1 expression was observed in the 1.5–80 µM Fe range. Shown is 
one of three similar experiments. Lower panel: densitometric analysis of the DMT1 bands shown in Figure 4A.
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IREG1 expression increases upon increasing iron exposure. Figure 5
IREG1 expression increases upon increasing iron exposure. IREG1 from cells cultured for 2 days with different iron concentra-
tions was determined by Western blot. A shows results of one of two similar experiments. Bands of 65.3 and 122.1 KDa were 
evident. The side panel shows the densitometric analysis of the bands. The 122.1 KDa band increased in the 1.5 to 40 mM Fe 
range. B: Both the upper, 122.1 KDa, band and the lower, 65.3 KDa, band diminished when the antibody was pre-incubated 
with peptide CGPDEKEVTKENQPNTSVV, prior to Western blot of 30, 20 and 10 mg of cell extract. C: treatment of 80 mM 
Fe extracts with increasing b-mercaptoethanol. A decrease in the 122.1 KDa band with increased b-mercaptoethanol was 
apparent.
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patients an intriguing question arises: Why do some neu-
rons die or present evident signs of degeneration while
others in the vicinity show a normal phenotype? Extrapo-
lating on the data presented here, it is tempting to hypoth-
esize that surviving neurons induce IREG1 expression
while sick neurons do not. Nevertheless, at present we
cannot exclude that other regulatory molecules may play
a pivotal role under these conditions.
Conclusions
Hippocampal neurons and SH-SY5Y cells displayed an
active system to regulate iron content. Nevertheless, this
system was unable to block iron accumulation which
resulted in death of part of the cell population. Another
fraction of the cell population developed an adaptative
mechanism that includes decreased expression of the
import transporter DMT1 and increased expression of fer-
ritin and the efflux transporter IREG1. The finding that
neurons regulate the expression of functional IREG1
opens new avenues for the understanding and possible
treatment of iron-related neurodegenerative processes.
Methods
Antibodies and immunodetection
Antibody D-1, prepared against the C-terminal end of the
IRE-containing isoform of DMT1 was used as described
Immunocytochemistry determination of IREG1 Figure 6
Immunocytochemistry determination of IREG1. Hippocampal neurons and SH-SY5Y cells, labeled with rabbit anti-
IREG1 antibody and with Alexa-546-conjugated goat anti-rabbit IgG, were imaged in a confocal microscope. Shown are repre-
sentative fields of cells cultured at different iron concentrations. Note the preferentially cytosolic distribution of IREG1.
B: SH-SY5Y cells
5 µM Fe 10 µM Fe 20 µM Fe 40 µM Fe
A: Hippocampal neurons
3 µM Fe 5 µM Fe 10 µM Fe 20 µM FeBMC Neuroscience 2005, 6:3 http://www.biomedcentral.com/1471-2202/6/3
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Kinetics of iron efflux from SH-SY5Y cells Figure 7
Kinetics of iron efflux from SH-SY5Y cells. SH-SY5Y cells were cultured for 2 days with varied amounts of iron as 
described in Figure 1A. The culture medium was changed to fresh DMEM and the kinetic of iron exit from the cells was fol-
lowed by determining the concentration of iron in the medium by absorption spectrometry (A). Data is means ± SD from 3 
experiments. The efflux rate, obtained from the slope of the curves in Figure 7A, was plotted against iron concentration during 
the 2-day culture period (B). In C, the efflux rate was plotted against the density of the 65.3 KDa or 122.1 KDa bands. To that 
end, the 65.3 KDa or 122.1 KDa bands shown in Figure 5 were quantified by densitometry and paired with the efflux rates 
determined in Figure 7A at the same iron concentrations. A good correlation between efflux rate and the presence of the 
122.1 KDa band was observed.
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previously [10]. Additionally, a rabbit polyclonal anti-
body against peptide CGPDEKEVTKENQPNTSVV,
corresponding to the consensus sequence of human, rat
and mouse carboxyl-terminal sequence of IREG1, was
obtained from BioSonda, Chile http://www.biosonda.cl.
Western analysis
Cell extracts, cells were prepared treating cells with lysis
buffer (50 µl per 1 × 106 cells of 10 mM MOPS, pH 7.5, 3
mM MgCl2, 40 mM KCl, 1 mM phenylmethylsulfonyl flu-
oride, 10 µg/ml leupeptin, 0.5 µg/ml aprotinin, 0.7 µg/ml
pepstatin A, 5% glycerol, 1 mM dithiothreitol, 0.1% Tri-
ton X-100). The mixture was incubated for 15 min on ice
and centrifuged for 10 min at 5,000 × g. Protein concen-
trations were determined using the bicinchoninic acid
(BCA) protein assay. The supernatant was stored at -70°C.
For Western analysis, 30 micrograms of protein from each
sample were boiled in Laemmli sample buffer for 5 min
and subjected to SDS-PAGE on a 7.5% acrylamide gel.
Proteins were transferred to nitrocellulose membrane and
blocked for 1 hr at 25°C with 5% nonfat dry milk in
blocking saline (20 mM Tris, 0.5 M NaCl, 0.05% Tween-
20). Membranes were incubated with primary antibody
overnight at 4°C, rinsed with blocking saline and incu-
bated with horseradish peroxidase-conjugated anti-rabbit
IgG antibody for 1 hr at 25°C. Transferred proteins were
detected with a peroxidase-based chemiluminiscence
assay kit (SuperSignal, Pierce Chem. Co., Rockford, IL).
Chemiluminiscence was detected using a Molecular
Imager FX device (Bio-Rad, Hercules, CA). The bands were
quantified by densitometry using the Quantity One (Bio-
Rad) software.
Cell culture and iron challenge
Human neuroblastoma SH-SY5Y cells (CRL-2266, Ameri-
can Type Culture Collection Rockville, MD), were seeded
at 1 × 105 cells in 2-cm2 plastic wells and cultured in a 5
% CO2 incubator in MEM/F12 medium supplemented
with 10 % fetal bovine serum and 5 mM glutamine. The
medium was replaced every two days. Under these condi-
tions, doubling time was about 48 hours. After 8 days in
culture, the culture reached a steady-state number of cells.
At this time, cells were challenged with iron for the next
two days as described [19]. In brief, low-iron culture
media was supplemented with either 1, 5, 10, 20, 40 or 80
µM Fe3+ as the complex FeCl3-sodium nitrilotriacetate.
Cell viability was quantified by the MTT assay (Molecular
Probes, OR) following the manufacturer's instructions.
This model of iron loading attempts to replicate neuronal
iron accumulation that occurs during life [4].
Hippocampal neurons were prepared from E18.5 rat
embryos [21]. Neurons were plated over poly-L-lysine
coated cover slips at 100,000 cells/cm2. Cultures were
maintained in 10% bovine serum until 3 hours after plat-
ing, when the culture medium was replaced with medium
containing B27 supplement [22]. After 3 days in culture,
the cells were challenged with iron as described above.
Labile iron pool
The intracellular labile or reactive iron pool of neuroblas-
toma cells was determined as described [23,24]. The
increase in fluorescence after the addition of SIH chelator
is directly proportional to the iron labile pool, i.e., iron in
complexes with affinity constant < 106.
Immunocytochemistry
Cells grown in cover slips were sequentially fixed with 2%
and 4% parafolmaldehyde (PFA) in Eagles' MEM, and
then washed three times with phosphate-buffered saline
(PBS). The fixed cells were permeabilized with Triton-X-
100 (0.2%) in PBS at room temperature for 3 min and
blocked with defatted milk (10%) in PBS for more than 1
h. The cells were incubated with anti-IREG1 antibody
(1:500) overnight at 4°C, washed with PBS and then incu-
bated with Alexa-546-conjugated goat anti-rabbit IgG.
The labeled cells were observed with a Zeiss LSM 510 Meta
confocal laser scanning microscope.
Data analysis
Variables were tested in triplicates, and experiments were
repeated at least twice. Variability among experiments was
<20%. One-way ANOVA was used to test differences in
mean values, and Turkey's post-hoc test was used for com-
parisons (In Stat program from GraphPad Prism). Differ-
ences were considered significant if P < 0.05.
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